Sector
Healthcare
Industry
Medical - Distribution
Employees
472
First IPO Date
December 28, 2007
| Name | Title | Pay | Year Born |
| Thomas Meier | CEO & Member of Executive Board | 0 | 1968 |
| Falk Neukirch | Executive Officer | 579,000 | 1971 |
| Christoph Prusseit | Chief Business Officer of Germany & Member of Executive Board | 589,000 | 1988 |
| Constantijn van Rietschoten | Chief Business Officer of International and Member of Executive Board | 589,000 | 1970 |
| Claudia Nickolaus | Head of Investor & Public Relations | 0 | N/A |
| Stefan Bauerreis | CFO & Member of the Executive Board | 0 | 1972 |
Medios AG, along with its affiliated entities, operates in Germany as a wholesaler specializing in niche pharmaceutical products. The company structures its operations into two main areas: Pharmaceutical Supply and Patient-Specific Therapies. The Pharmaceutical Supply division provides a diverse range of products aimed at conditions within oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia. Conversely, the Patient-Specific Therapies segment focuses on creating bespoke medications for individual patients, frequently on behalf of pharmacies, and also prepares personalized treatments that involve precisely dosed tablets. Medios AG was founded in 2016 and maintains its corporate headquarters in Berlin, Germany.